BRANDI TIPPLE: Open Payments
NPI 1780229682 · LANCASTER, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 67 payments from 18 companies in 2025. Trend: 2023 $554 · 2024 $793 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 29 | $343 |
| Edwards Lifesciences Corporation | 1 | $133 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $106 |
| Amgen Inc. | 6 | $100 |
| PFIZER INC. | 4 | $69 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Supernus Pharmaceuticals, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| Axsome Therapeutics, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
Products named: VRAYLAR, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), CAPLYTA, QULIPTA, SHINGRIX, OTEZLA, UBRELVY, Qelbree.
Industry payments across OH — which companies pay providers there.
